Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. - Archive ouverte HAL Access content directly
Journal Articles Circulation Research Year : 2011

Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.

(1) , (1) , (2) , (1) , (1) , (1) , (1) , (1) , (3) , (4) , (1) , (2) , (1)
1
2
3
4

Abstract

Rationale: Senescence of pulmonary artery smooth muscle cells (PA-SMCs) caused by telomere shortening or oxidative stress may contribute to pulmonary hypertension associated with chronic lung diseases. Objective: To investigate whether cell senescence contributes to pulmonary vessel remodeling and pulmonary hypertension in chronic obstructive pulmonary disease (COPD). Methods and Results: In 124 patients with COPD investigated by right heart catheterization, we found a negative correlation between leukocyte telomere length and pulmonary hypertension severity. In-depth investigations of lung vessels and derived cultured PA-SMCs showed greater severity of remodeling and increases in senescent p16-positive and p21-positive PA-SMCs and proliferating Ki67-stained cells in 14 patients with COPD compared to 13 age-matched and sex-matched control subjects who smoke. Cultured PA-SMCs from COPD patients displayed accelerated senescence, with fewer cell population doublings, an increased percentage of β-galactosidase-positive cells, shorter telomeres, and higher p16 protein levels at an early cell passage compared to PA-SMCs from controls. Both in situ and in vitro PA-SMC senescence criteria correlated closely with the degree of pulmonary vessel wall hypertrophy. Because senescent PA-SMCs stained for p16 and p21 were virtually confined to the media near the Ki67-positive cells, which predominated in the neointima and hypertrophied media, we evaluated whether senescent cells affected normal PA-SMC functions. We found that senescent PA-SMCs stimulated the growth and migration of normal target PA-SMCs through the production and release of paracrine soluble and insoluble factors. Conclusion: PA-SMC senescence is an important contributor to the process of pulmonary vascular remodeling that underlies pulmonary hypertension in chronic lung disease.
Fichier principal
Vignette du fichier
text_Circ_Res_and_online_S_241299_R2_aw_.pdf (1.21 Mo) Télécharger le fichier
Vignette du fichier
inserm-00618219_edited.pdf (713.2 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00618219 , version 1 (10-01-2012)

Identifiers

Cite

Hibo Noureddine, Guillaume Gary-Bobo, Marco Alifano, Elisabeth Marcos, Mirna Saker, et al.. Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.: Role of Cell Senescence in Pulmonary Hypertension. Circulation Research, 2011, 109 (5), pp.543-53. ⟨10.1161/CIRCRESAHA.111.241299⟩. ⟨inserm-00618219⟩
167 View
748 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More